Endo Faces Securities Suit Over Unit's Price-Fixing Probe
An Endo investor on Monday lodged a proposed class action in New York federal court accusing the drugmaker of failing to disclose that its subsidiary Par Pharmaceutical may have colluded with...To view the full article, register now.
Already a subscriber? Click here to view full article